polysulfone P 1700 (UDEL)

03/01/1997 - "Prospective, controlled study in patients with continuous venovenous hemofiltration (24 1/24 h) using a polysulphone membrane in patients with acute renal failure. "
01/01/2006 - "In a prospective study, 11 procedures with a polysulfone membrane were performed in nine critically ill patients with acute renal failure and impaired hemostasis. "
01/01/2002 - "Twelve critically ill patients (five female, seven male) with acute renal failure undergoing CVVH using a 0.7 m(2) polysulphone high-flux membrane were investigated. "
08/01/2006 - "Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure."
03/01/1997 - "The study indicates that low volume continuous hemofiltration with polysulphone membranes in patients with acute renal failure is not able to induce significant removal of cytokines."

04/01/2003 - "In this acute endotoxic shock model, CVVH with the polyacrylonitrile membrane improved cardiac performance when compared with the polysulphone membrane. "
04/01/2003 - "Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock."
04/01/2003 - "This study was designed to compare the effects of continuous venovenous hemofiltration (CVVH) with two different membranes, polysulphone and polyacrylonitrile (AN69), on global and regional hemodynamics, plasma lactate, tumor necrosis factor-alpha levels, and plasma nitrite/nitrate during endotoxic shock in dogs. "

04/01/2015 - "Recently, hypotension and malaise during hemodialysis using polysulfone (PS) membranes have been reported. "
03/01/2010 - "Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer."
09/01/2001 - "Cuprophan membrane was more reuseable and was associated with fewer episodes of hypotension, while polysulfone was associated with fewer episodes of first use reactions. "
09/01/2001 - "Hypotension occurred in 12% and 29% of dialyses with cuprophan and polysulfone dialyzers (P < 0.001), and the difference persisted, but the frequency in each membrane group decreased, with reuse (P < 0.001). "
01/01/2007 - "The frequency of hypertension episodes was similar during the hemodialysis with different dialyzers, but the incidence of different symptoms and hypotension episodes was significantly lower during hemodialysis with polysulfone membrane. "

06/01/2010 - "A patient is described who developed dialysis-associated thrombocytopenia using a Fresenius Medical Care Optiflux polysulfone membrane (F-160) that significantly improved when switched to the polysulfone Asahi REXEED 25S membrane (AR-25S). "
01/01/2013 - "Although we were unable to elucidate the exact biochemical mechanism, the cause of the thrombocytopenia in this series appears to be related to the type of polysulfone and not due to the sterilization technique."
01/01/2013 - "The thrombocytopenia resolved after switching to either of 2 polysulfone membranes, one of which also was electron-beam sterilized. "
01/01/2013 - "However, despite better biocompatibility, thrombocytopenia has been observed in patients who are dialyzed with various polysulfone membranes. "
07/01/2012 - "Most recent cases of dialysis-associated thrombocytopenia have been with polysulfone membranes, especially polysulfone membranes sterilized by electron beam. "

04/01/2007 - "The hypothesis tested was that improved clearances of middle molecules with the FX80 membrane would lead to less oxidative stress and inflammation compared with the high-flux polysulfone (HF80) membrane. "
01/01/2014 - "Therefore, we used a polysulfone dialyzer to reduce the oxidative stress and inflammation while preserving vascular endothelial function. "
01/01/2009 - "Dialysis patients who use polysulfone dialyzers are less likely to have inflammation. "
01/01/2009 - "The FX class of haemodialysers features a new class of high-flux polysulfone membrane which has been suggested to induce less inflammation. "
04/01/2007 - "Long-term dialysis with a Helixone membrane did not modify any parameters of oxidative stress or inflammation in this stable hemodialysis population compared with a high-flux polysulfone dialysis membrane."